Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Knee Surgery, Sports Traumatology, Arthroscopy
Published in: Knee Surgery, Sports Traumatology, Arthroscopy 1/2016

01-01-2016 | Knee

Combined arthroscopic and open synovectomy for diffuse pigmented villonodular synovitis of the knee

Authors: Brent Mollon, Anthony M. Griffin, Peter C. Ferguson, Jay S. Wunder, John Theodoropoulos

Published in: Knee Surgery, Sports Traumatology, Arthroscopy | Issue 1/2016

Login to get access

Abstract

Purpose

There are few reports detailing recurrence rates or functional outcomes after combined arthroscopic and open synovectomy to treat diffuse pigmented villonodular synovitis (DPVNS) of the knee.

Methods

Patients with DPVNS of the knee treated with combined synovectomy, followed for a minimum of 12 months at a tertiary orthopaedic oncology centre, were identified. We extracted data pertaining to demographics, complications, clinical outcomes and recurrence. Functional status was evaluated prospectively using the Toronto Extremity Salvage Score (TESS) and the Musculoskeletal Tumor Society (MSTS) 1987 and 1993 surveys. Data were reported descriptively as mean (SD) unless otherwise specified.

Results

Fifteen patients [80 % female; mean age 38.9 (SD 14.2) years] representing 15 knees were treated with combined synovectomies and followed for 81 (SD 55) months. Posterior arthroscopy was utilized in 73 % of patients. External beam radiation was utilized post-operatively in 73 % of patients. Two patients (13 %) experienced symptomatic disease recurrence. The mean post-operative knee range of motion was 1° (range 0–10°) to 115° (range 90–135°). TESS and MSTS 1987/1993 scores all suggested excellent patient function. Post-operative complications included one posterior wound dehiscence, one case of femoral condyle avascular necrosis and one patient with lymphedema.

Conclusions

Combined synovectomy resulted in a low rate of symptomatic disease recurrence and good to excellent functional outcomes for diffuse PVNS of the knee. A literature review identified this as largest case series focusing on combined synovectomies for DPVNS of the knee and the only one describing functional outcomes or the use of external beam radiotherapy.

Level of evidence

Retrospective case series, Level IV.
Literature
1.
Akgun I, Ogut T, Kesmezacar H, Dervisoglu S (2003) Localized pigmented villonodular synovitis of the knee. Orthopedics 26:1131–1135PubMed
2.
Berger B, Ganswindt U, Bamberg M, Hehr T (2007) External beam radiotherapy as postoperative treatment of diffuse pigmented villonodular synovitis. Int J Radiat Oncol Biol Phys 67(4):1130–1134PubMedCrossRef
3.
Blanco CE, Leon HO, Guthrie TB (2001) Combined partial arthroscopic synovectomy and radiation therapy for diffuse pigmented villonodular synovitis of the knee. Arthroscopy 17(5):527–531PubMedCrossRef
4.
5.
Chen WM, Wu PK, Liu CL (2012) Simultaneous anterior and posterior synovectomies for treating diffuse pigmented villonodular synovitis. Clin Orthop Relat Res 470(6):1755–1762PubMedPubMedCentralCrossRef
6.
Chin KR, Barr SJ, Winalski C, Zurakowski D, Brick GW (2002) Treatment of advanced primary and recurrent diffuse pigmented villonodular synovitis of the knee. J Bone Joint Surg Am 84(12):2192–2202PubMed
7.
Colman MW, Ye J, Weiss KR, Goodman MA, McGough RL III (2012) Does combined open and arthroscopic synovectomy for diffuse PVNS of the knee improve recurrence rates? Clin Orthop Relat Res 471(3):883–890PubMedCentralCrossRef
8.
Davis AM, Wright JG, Williams JI, Bombardier C, Griffin A, Bell RS (1996) Development of a measure of physical function for patients with bone and soft tissue sarcoma. Qual Life Res 5(5):508–516PubMedCrossRef
9.
de Carvalho LH Jr, Soares LF, Goncalves MB, Temponi EF, de Melo Silva O Jr (2012) Long-term success in the treatment of diffuse pigmented villonodular synovitis of the knee with subtotal synovectomy and radiotherapy. Arthroscopy 28(9):1271–1274PubMedCrossRef
10.
De Ponti A, Sansone V, Malchere M (2003) Result of arthroscopic treatment of pigmented villonodular synovitis of the knee. Arthroscopy 19(6):602–607PubMedCrossRef
11.
Gonzalez Della Valle A, Piccaluga F, Potter HG, Salvati EA, Pusso R (2001) Pigmented villonodular synovitis of the hip: 2- to 23-year followup study. Clin Orthop Relat Res 388:187–199PubMedCrossRef
12.
Docken WP (1979) Pigmented villonodular synovitis: a review with illustrative case reports. Semin Arthritis Rheum 9(1):1–22PubMedCrossRef
13.
Enneking W (1987) Modification of the system for functional evaluation of the surgical management of musculoskeletal tumors. In: Enneking W (ed) Limb salvage in musculoskeletal oncology. Churchill Livingstone, New York, pp 626–639
14.
Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ (1993) A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res 286:241–246PubMed
15.
Fiocco U, Sfriso P, Lunardi F, Pagnin E, Oliviero F, Scagliori E, Cozzi L, Vezzu M, Molena B, Scanu A, Panziera C, Nardacchione R, Rubaltelli L, Dayer JM, Calabrese F, Punzi L (2010) Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitis. Autoimmun Rev 9(11):780–784PubMedCrossRef
16.
Flandry F, Hughston JC, McCann SB, Kurtz DM (1994) Diagnostic features of diffuse pigmented villonodular synovitis of the knee. Clin Orthop Relat Res 298:212–220PubMed
17.
Goldman AB, DiCarlo EF (1988) Pigmented villonodular synovitis. Diagnosis and differential diagnosis. Radiol Clin North Am 26(6):1327–1347PubMed
18.
Griffin AM, Ferguson PC, Catton CN, Chung PWM, White LM, Wunder JS, Bell RS, O’Sullivan B (2012) Long-term outcome of the treatment of high-risk tenosynovial giant cell tumor/pigmented villonodular synovitis with radiotherapy and surgery. Cancer 118(19):4901–4909PubMedCrossRef
19.
Heyd R, Micke O, Berger B, Eich HT, Ackermann H, Seegenschmiedt MH, German Cooperative Group on Radiotherapy for Benign Diseases (2010) Radiation therapy for treatment of pigmented villonodular synovitis: results of a national patterns of care study. Int J Radiat Oncol Biol Phys 78(1):199–204CrossRef
20.
Jaffe H, Lichtenstein L, Sutro C (1941) Pigmented villonodular synovitis, bursitis and tenosynovitis: a discussion of the synovial and bursal equivalents of the tenosynovial lesion commonly denoted as xanthoma, xanthogranuloma, giant cell tumor or myeloplaxoma of tendon sheath with some consideration of this tendon sheath lesion itself. Arch Pathol 31:731–765
21.
Johansson JE, Ajjoub S, Coughlin LP, Wener JA, Cruess RL (1982) Pigmented villonodular synovitis of joints. Clin Orthop Relat Res 163:159–166PubMed
22.
Martin RC, Osborne DL, Edwards MJ, Wrightson W, McMasters KM (2000) Giant cell tumor of tendon sheath, tenosynovial giant cell tumor, and pigmented villonodular synovitis: defining the presentation, surgical therapy and recurrence. Oncol Rep 7(2):413–419PubMed
23.
Myers BW, Masi AT (1980) Pigmented villonodular synovitis and tenosynovitis: a clinical epidemiologic study of 166 cases and literature review. Medicine 59(3):223–238PubMedCrossRef
24.
Nakahara H, Matsuda S, Harimaya K, Sakamoto A, Matsumoto Y, Okazaki K, Tashiro Y, Iwamoto Y (2012) Clinical results of open synovectomy for treatment of diffuse pigmented villonodular synovitis of the knee: case series and review of literature. Knee 19(5):685–687CrossRef
25.
Nielsen AL, Kiaer T (1989) Malignant giant cell tumor of synovium and locally destructive pigmented villonodular synovitis: ultrastructural and immunohistochemical study and review of the literature. Hum Pathol 20(8):765–771PubMedCrossRef
26.
Nishida Y, Tsukushi S, Nakashima H, Sugiura H, Yamada Y, Urakawa H, Arai E, Ishiguro N (2012) Osteochondral destruction in pigmented villonodular synovitis during the clinical course. J Rheumatol 39(2):345–351PubMedCrossRef
27.
Oehler S, Fassbender HG, Neureiter D, Meyer-Scholten C, Kirchner T, Aigner T (2000) Cell populations involved in pigmented villonodular synovitis of the knee. J Rheumatol 27(2):463–470PubMed
28.
Ogilvie-Harris DJ, McLean J, Zarnett ME (1992) Pigmented villonodular synovitis of the knee. The results of total arthroscopic synovectomy, partial, arthroscopic synovectomy, and arthroscopic local excision. J Bone Joint Surg Am 74(1):119–123PubMed
29.
Ottaviani S, Ayral X, Dougados M, Gossec L (2011) Pigmented villonodular synovitis: a retrospective single-center study of 122 cases and review of the literature. Semin Arthritis Rheum 40(6):539–546PubMedCrossRef
30.
Park G, Kim YS, Kim JH, Lee SW, Song SY, Choi EK, Yi SY, Ahn SD (2012) Low-dose external beam radiotherapy as a postoperative treatment for patients with diffuse pigmented villonodular synovitis of the knee. Acta Orthopaedica 83(3):256–260PubMedPubMedCentralCrossRef
31.
Perka C, Labs K, Zippel H, Buttgereit F (2000) Localized pigmented villonodular synovitis of the knee joint: neoplasm or reactive granuloma? A review of 18 cases. Rheumatology 39(2):172–178PubMedCrossRef
32.
Rao AS, Vigorita VJ (1984) Pigmented villonodular synovitis (giant-cell tumor of the tendon sheath and synovial membrane). A review of eighty-one cases. J Bone Joint Surg Am 66(1):76–94PubMed
33.
Schwartz HS, Unni KK, Pritchard DJ (1989) Pigmented villonodular synovitis. A retrospective review of affected large joints. Clin Orthop Relat Res 247:243–255PubMed
34.
35.
Tyler WK, Vidal AF, Williams RJ, Healey JH (2006) Pigmented villonodular synovitis. J Am Acad Orthop Surg 14(6):376–385PubMed
36.
Ward WG Sr, Boles CA, Ball JD, Cline MT (2007) Diffuse pigmented villonodular synovitis: preliminary results with intralesional resection and p32 synoviorthesis. Clin Orthop Relat Res 454:186–191PubMedCrossRef
37.
West RB, Rubin BP, Miller MA, Subramanian S, Kaygusuz G, Montgomery K, Zhu S, Marinelli RJ, De LA, Downs-Kelly E, Goldblum JR, Corless CL, Brown PO, Gilks CB, Nielsen TO, Huntsman D, van de Rijn M (2006) A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci USA 103(3):690–695PubMedPubMedCentralCrossRef
38.
Zvijac JE, Lau AC, Hechtman KS, Uribe JW, Tjin ATE (1999) Arthroscopic treatment of pigmented villonodular synovitis of the knee. Arthroscopy 15(6):613–617PubMedCrossRef
Metadata
Title
Combined arthroscopic and open synovectomy for diffuse pigmented villonodular synovitis of the knee
Authors
Brent Mollon
Anthony M. Griffin
Peter C. Ferguson
Jay S. Wunder
John Theodoropoulos
Publication date
01-01-2016
Publisher
Springer Berlin Heidelberg
Published in
Knee Surgery, Sports Traumatology, Arthroscopy / Issue 1/2016
Print ISSN: 0942-2056
Electronic ISSN: 1433-7347
DOI
https://doi.org/10.1007/s00167-014-3375-9

Other articles of this Issue 1/2016

Knee Surgery, Sports Traumatology, Arthroscopy 1/2016 Go to the issue

Knee

Clinical outcome after UKA and HTO in ACL deficiency: a systematic review

Knee

Magnetic resonance angiography evaluation of the bone tunnel and graft following ACL reconstruction with a hamstring tendon autograft

Knee

The effect of feedback from post-operative 3D CT on placement of femoral tunnels in single-bundle anatomic ACL reconstruction

Knee

The difference in centre position in the ACL femoral footprint inclusive and exclusive of the fan-like extension fibres

Knee

No difference in clinical outcomes after total knee arthroplasty between patellar eversion and non-eversion

Knee

Influence of the tourniquet on tibial cement mantle thickness in primary total knee arthroplasty